Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC)

Published:2017-09 Issue: Volume:50 Page:263-269
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Gu Yuanlong,Lv Huimin,Zhao Juan,Li Qi,Mu Guannan,Li Jiade,Wuyang Jiazi,Lou Ge,Wang Ruitao,Zhang Yanqiao,Huang Xiaoyi

Funder

Haiyan Foundation of Harbin Medical University Cancer Hospital

Heilongjiang Innovation Ability Promoting Program for Scientific Research Institutions

Harbin Science and Technology Bureau

Heilongjiang Applied Technology Research and Development Program

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Non-small cell lung cancer, version 2.2013;Ettinger;J. Natl. Compr. Cancer Netw.,2013

3. The future of cancer vaccines for non-small-cell lung cancer: ongoing trials;Choudhury;Clin. Lung Cancer,2008

4. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer;Mac Manus;Cancer,2006

5. The evolving role of histology in the management of advanced non-small-cell lung cancer;Langer;J. Clin. Oncol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines;Frontiers in Oncology;2022-05-11

2. Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy;Journal of Cellular Physiology;2020-06-02

3. Clinical Trials with Cytokine-Induced Killer Cells and CAR-T Cell Transplantation for Non-small Cell Lung Cancer Treatment;Advances in Experimental Medicine and Biology;2020

4. Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer;Clinical & Translational Immunology;2020-01

5. Enhanced metabolic activities for ATP production and elevated metabolic flux via pentose phosphate pathway contribute for better CIK cells expansion;Cell Proliferation;2019-03-07